Elizabeth Hirak Field

Elizabeth Hirak Field

Auto-generated profile, based on publicly available information

Elizabeth Hirak Field

Department of Veterans Affairs Medical Center, Iowa City, IA 52246, USA

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
PLPetar Lenert
Petar Lenert
RBRachel Brummel
Rachel Brummel
EFElizabeth H. Field
Elizabeth H. Field
RARobert F. Ashman
Robert F. Ashman

1 September 1993 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
HWH. James Williams
H. James Williams
JWJohn R. Ward
John R. Ward
MEMarlene J. Egger
Marlene J. Egger
RNRosemarie Neuner
Rosemarie Neuner
RBRaye H. Brooks
Raye H. Brooks
JSJohn T. Sharp
John T. Sharp

15 April 1995 in Transplantation
Verified
Journal Article
Closed access
NCNaixi Chen
Naixi Chen
EFElizabeth H. Field
Elizabeth H. Field
We examined the cytokine profiles associated with tolerance and rejection using the mouse model of neonatal tolerance. BALB/c mice primed with CAF1 splenocytes during the neonatal stage showed increased A/J skin graft survival of >60 days and failed to develop anti-A/J cytotoxic responses, but rejected third-party C57BL/6 grafts. Lymph node cells that drained A/J grafts on neonatal-primed mice produced allospecific immune cytokine responses characterized by high IL-4 and low IFN-γ levels. In contrast, lymph node cells that drained either rejected third-party grafts or rejected A/J grafts placed on adult controls produced less IL-4 and more IFN-γ. Tolerogen-specific immune responses from neonatal-primed mice made up to 100 times higher IL-4 to IFN-γ ratios than did controls. Alloantigen priming during the immediate neonatal stage induced constitutive expression of IL-4 mRNA in the spleen without IFN-g mRNA, whereas alloantigen stimulation during adulthood induced the opposite pattern. IL-4 production from neonatal primed mice was confined to the CD4 population. The altered cytokine profile of enhanced IL-4/IFN-γ in neonatal primed mice persisted for up to 12 weeks after priming in in vitro secondary MLR assays, which suggests that the initial timing of antigen stimulation critically influenced CD4 maturation. The results support a model of immunoredirection as a mechanism of tolerance and provide rationale for examining the therapeutic use of cytokines in transplantation.

1 March 2014 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
ASAudrey F. Saftlas
Audrey F. Saftlas
LRLinda Rubenstein
Linda Rubenstein
KPKaitlin Prater
Kaitlin Prater
KHKarisa K. Harland
Karisa K. Harland
EFElizabeth Field
Elizabeth Field
ETElizabeth W. Triche
Elizabeth W. Triche

15 April 1996 in Transplantation
Verified
Journal Article
Closed access
NCNaixi Chen
Naixi Chen
QGQinglin Gao
Qinglin Gao
EFElizabeth H. Field
Elizabeth H. Field
We investigated the role of Th1 and Th2 cytokines in rejection and tolerance using the neonatal tolerance model. We reported previously that lymph nodes that drained immunogen-bearing tolerant grafts produced a 10- to 100-fold higher ratio of interleukin (IL)-4 to interferon (IFN)-γ compared with lymph node cells from rejected grafts. Moreover, because neonatal antigen exposure triggers allospecific Th2 CD4 memory cells, whereas antigen exposure during adulthood triggers Th1 CD4 memory cells, we speculated that immunoredirection toward Th2 and away from Th1 functions as another mechanism of tolerance. To test the immunoredirection hypothesis, we examined whether recovery of Th1 cytokine responses abrogates tolerance. We now show that treatment with exogenous IFN-γ at the time of neonatal priming recovered mixed lymphocyte reaction hypoproliferation and restored the ability of mice to reject skin grafts. Mice that received IFN-γ at the time of neonatal priming produced more IFN-γ and contained more A/J-reactive IFN-γ-producing CD4 cells compared with untreated neonatal primed mice, but failed to recover A/J-specific IFN-γ-producing CD8 cells or CTL responses, which suggests that graft rejection occurred via Th1 CD4 cells. Interestingly, draining lymph node cells from rejected grafts on IFN-γ-treated neonatal primed mice also produced more IL-4, compared with cells from healthy grafts on untreated neonatal primed mice. Nonetheless, lower IL-4 to IFN-γ ratios predicted graft rejection and higher ratios predicted acceptance. We conclude that neonatal tolerance depends on the ability to block generation of allospecific Th1 responses that lead to rejection. Thus, immunoredirection involves both the inhibition of Th1 and expansion of Th2 immune responses.

1 April 1985 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
SSSamuel Strober
Samuel Strober
EFElizabeth Field
Elizabeth Field
RHRichard T. Hoppe
Richard T. Hoppe
BKBrian L. Kotzin
Brian L. Kotzin
OSOvadia Shemesh
Ovadia Shemesh
BMBryan D. Myers
Bryan D. Myers
Ten patients with lupus nephritis and marked proteinuria (3.9 g or more/d) that did not respond adequately to treatment with prednisone alone or prednisone in combination with azathioprine were treated with total lymphoid irradiation in an uncontrolled feasibility study. Within 6 weeks after the start of total lymphoid irradiation, the serum albumin level rose in all patients in association with a reduction in the serum level of anti-DNA antibodies, an increase in the serum complement level, or both. Improvement in these variables persisted in eight patients followed for more than 1 year, with the stabilization or reduction of the serum creatinine level. Urinary leakage of albumin was substantially reduced in all patients. Side effects associated with radiotherapy included transient constitutional complaints in ten patients, transient blood element depressions in three, localized viral and bacterial infections in four, and ovarian failure in one. The results suggest that total lymphoid irradiation may provide an alternative to cytotoxic drugs in the treatment of lupus nephritis.